
Top ten pharmaceutical merger and acquisition deals by value 2014
This statistic describes the top 10 merger and acquisition deals worldwide within the pharmaceutical industry in 2014, based on deal value. In that year, Roche acquired InterMune in a deal valued at 8.3 billion U.S. dollars. Merger and acquisitions become more common as cash-rich companies aim to reorganize their companies.